Stock Taper
EARNINGS CALL ARCHIVE 3 CALLS ON FILE
BCAX — Bicara Therapeutics Inc. Common Stock
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 11, 2026
REVENUE
$0
EPS
-$0.93 -36.8%
FREE CASH FLOW
-$37.6M -55.7%

No summary has been written for this call yet.